DSIJ Mindshare

Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility

The inspection, conducted between December 9 and December 17, 2024, resulted in two procedural observations from the US FDA.

Manoj Reddy Sama 0 104 Article rating: 4.3

The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site operated by Apitoria Pharma Private Ltd, a wholly owned subsidiary of Aurobindo Pharma, located in Pashamylaram Village, Telangana.

 

Leading Battery Manufacturer in India Invests Rs 100 Crore in Clean Energy Subsidiary

The investment is part of a rights issue in which EESL has allotted 2,77,77,777 equity shares of Rs 10 each, at a premium of Rs 26 per share, totaling Rs 99.99 crore.

Manoj Reddy Sama 0 148 Article rating: 3.7

The funds raised through this investment will be used to support EESL’s greenfield project in Bengaluru, where the subsidiary is setting up a manufacturing plant for lithium-ion battery cells, modules, and packs

Smallcap IT company Launches AI-Powered Test Acceleration Platform to Drive Digital Transformation

IntellQA, powered by Sonata Harmoni.AI Workbench, enables enterprises to respond swiftly to market demands by accelerating the delivery of high-quality software

Manoj Reddy Sama 0 150 Article rating: 5.0

IntellQA's capabilities collectively drive enhanced ROI, long-term cost savings, and a stronger bottom line, making IntellQA an essential enabler of enterprise-scale AI transformation.

 

Market capitalization Rs 1700 Crore: Company receives Rs 200 crore order from Assam Gas Company Ltd

The total contract value is approximately Rs 200 crores, with around Rs 82 crores to be realized in the first year on a Free on Truck (FOT) site basis, which includes freight, unloading, and stacking but excludes GST.

Manoj Reddy Sama 0 172 Article rating: 3.5

The company has secured an order from Assam Gas Company Limited for the supply of a Compressor Station on a Build, Own, Operate, and Transfer (BOOT) basis for a period of three years.

 

RSS
1345678910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR